catechin has been researched along with Ureteral Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, X; Du, F; Liu, N; Su, X; Sun, G; Wang, B; Wang, Y; Zhou, G | 1 |
| Bian, X; Du, F; Li, D; Liu, N; Su, X; Sun, G; Wang, B; Wang, Y | 1 |
2 other study(ies) available for catechin and Ureteral Obstruction
| Article | Year |
|---|---|
Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation.
Topics: Animals; Bilirubin; Catechin; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Heme Oxygenase-1; Inflammation; Kidney; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction; Ureteral Obstruction | 2015 |
Epigallocatechin-3-gallate reduces tubular cell apoptosis in mice with ureteral obstruction.
Topics: Animals; Apoptosis; Biomarkers; Blotting, Western; Catechin; Cell Line; Flow Cytometry; In Situ Nick-End Labeling; Kidney Tubules; MAP Kinase Signaling System; Mice; Protective Agents; Rats; Ureteral Obstruction | 2015 |